Skip to main content
. 2005 Jun 23;65(1):35–39. doi: 10.1136/ard.2005.038851

Table 1 Disease related characteristics of 90 patients with rheumatoid arthritis with or without etanercept.

Characteristic Etanercept group (n = 52) Control group (n = 38) p Value
Age (years) 53 (20 to 80) 52 (20 to 69) 0.223
Women (%) 90 87
Duration of disease (years) 9.5 (1 to 20) 8 (1 to 21) 0.882
Methotrexate (mg) 7.5 (0 to 20) 7.5 (0 to 20) 0.551
DMARDs except methotrexate (n) 1.5 (1 to 3) 1 (1 to 3) 0.954

Values are median (range).

DMARD, disease modifying antirheumatic drug.